Get started
MMM

MEDADVISOR LIMITED

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

MDR chart


Full chart

MDR upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪151.61 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
580.000
Basic EPS (TTM)
0.000 AUD
Net income (FY)
‪792.13 K‬ AUD
Revenue (FY)
‪122.11 M‬ AUD
Shares float
‪317.54 M‬
Beta (1Y)
0.61

About MEDADVISOR LIMITED


Sector
Technology Services
Industry
Packaged Software
CEO
Richard Ratliff
Website
medadvisor.com.au
Headquarters
Camberwell
Founded
2010
ISIN
AU000000MDR6
FIGI
BBG001LRVJF2
MedAdvisor Ltd. engages in the provision of pharmacy-driven, innovative patient engagement solutions that simplify the patient medication journey to empower better health. It operates through the following segments: Australia and New Zealand Operations, the United States Operations, the United Kingdom Operations, Asia Operations, and Corporate. The company was founded by Joshua Swinnerton in 2010 and is headquartered in Camberwell, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

MDR news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MDR is 0.300 AUD — it has increased by 5.45% in the past 24 hours. Watch MEDADVISOR LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange MEDADVISOR LIMITED stocks are traded under the ticker MDR.
MDR stock has risen by 11.54% compared to the previous week, the month change is a −22.67% fall, over the last year MEDADVISOR LIMITED has showed a 57.89% increase.
We've gathered analysts' opinions on MEDADVISOR LIMITED future price: according to them, MDR price has a max estimate of 0.62 AUD and a min estimate of 0.45 AUD. Watch MDR chart and read a more detailed MEDADVISOR LIMITED stock forecast: see what analysts think of MEDADVISOR LIMITED and suggest that you do with its stocks.
MDR reached its all-time high on May 26, 2011 with the price of 1.725 AUD, and its all-time low was 0.085 AUD and was reached on Dec 20, 2013. View more price dynamics on MDR chart.
See other stocks reaching their highest and lowest prices.
MDR stock is 3.45% volatile and has beta coefficient of 0.61. Track MEDADVISOR LIMITED stock price on the chart and check out the list of the most volatile stocks — is MEDADVISOR LIMITED there?
Today MEDADVISOR LIMITED has the market capitalization of ‪151.61 M‬, it has increased by 2.00% over the last week.
Yes, you can track MEDADVISOR LIMITED financials in yearly and quarterly reports right on TradingView.
MEDADVISOR LIMITED is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
MDR earnings for the last half-year are −0.01 AUD per share, whereas the estimation was −0.01 AUD, resulting in a 9.09% surprise. The estimated earnings for the next half-year are 0.02 AUD per share. See more details about MEDADVISOR LIMITED earnings.
MEDADVISOR LIMITED revenue for the last half-year amounts to ‪46.60 M‬ AUD, despite the estimated figure of ‪43.05 M‬ AUD. In the next half-year revenue is expected to reach ‪79.55 M‬ AUD.
MDR net income for the last half-year is ‪−6.08 M‬ AUD, while the previous report showed ‪6.87 M‬ AUD of net income which accounts for −188.47% change. Track more MEDADVISOR LIMITED financial stats to get the full picture.
No, MDR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDADVISOR LIMITED EBITDA is ‪6.89 M‬ AUD, and current EBITDA margin is 5.64%. See more stats in MEDADVISOR LIMITED financial statements.
Like other stocks, MDR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDADVISOR LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDADVISOR LIMITED technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDADVISOR LIMITED stock shows the sell signal. See more of MEDADVISOR LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.